Genesis_logo

GENetics and the Electrocardiogram for predicting Scd rISk

MARIE SKŁODOWSKA-CURIE ACTIONS
Individual Fellowships (IF)

In February 2018, I received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 786833 to carry out the project GENESIS, with a budget of €183,454.80 for a duration of two years.

Sudden cardiac death (SCD) is a common and devastating event, often occurring in the prime of life and having profound consequences for surviving members of the individual’s family. Consequently, enhancement of methods for prediction and prevention of SCD are critically important. A better risk assessment can only be established if there is deeper understanding of the mechanisms leading to SCD. The main objective of GENESIS is to establish and test a novel effective approach to prevent SCD based on the combination of information derived from cardiac electrophysiological indices and genetic predisposition.